Evaluating the Cardiovascular Safety of Naltrexone/Bupropion in the United States

被引：0

作者：

Burns, Dustin ^{[1
]}

Kyle, Michael L. ^{[2
]}

Murray, Catherine Rogers ^{[1
]}

Watson, Heather ^{[1
]}

Swaney, Jeff R. ^{[1
]}

Spevack, Samuel ^{[3
]}

Leonhard, Megan ^{[1
]}

Simon, Michael A. ^{[1
]}

Moynihan, Emma

Lapane, Kate L. ^{[4
]}

Wang, Shirley V. ^{[5
]}

Longo, Craig ^{[6
]}

Ritchey, Mary E. ^{[7
]}

Dore, David ^{[1
]}

机构：

[1] Exponent Inc, Menlo Pk, CA USA

[2] Currax Pharmaceut, Brentwood, Essex, England

[3] Exponent, Menlo Pk, CA USA

[4] Consultant Exponent, Menlo Pk, CA USA

[5] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA USA

[6] APHMFP, Providence, RI USA

[7] CERobs Consulting LLC, Chapel Hill, NC USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

540

引用

页码：224 / 224

页数：1

共 50 条

[11] Comparative Cardiovascular Safety of Testosterone Formulations in the United States and United Kingdom
Layton, J. Bradley
Sharpless, Julie L.
Meier, Christoph R.
Stuermer, Til
Jick, Susan S.
Brookhart, M. Alan
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 187 - 188
[12] Bupropion and naltrexone for the treatment of obesity
Greenway, Frank L.
Anderson, James W.
Atkinson, Richard L.
Fujioka, Ken
Gadde, Kishore M.
Gupta, Alok K.
O'Neil, Patrick M.
Schumacher, Donald
Smith, Diane K.
Whitehouse, M. J.
Cruickshank, Scott
Guttadauria, Maria
Cowley, Michael A.
DIABETES, 2006, 55 : A394 - A394
[13] Naltrexone and bupropion for weight loss
Thomas, Betsy
Lindblad, Adrienne J.
Luu, Thao
Paige, Allison
CANADIAN FAMILY PHYSICIAN, 2023, 69 (09) : E179 - E180
[14] Naltrexone/bupropion prolonged release
Llano, Andrea
PRACTICAL DIABETES, 2015, 32 (03) : 114 - 115
[15] Naltrexone-bupropion for weight loss
Thomas, Betsy
Lindblad, Adrienne J.
Luu, Thao
Paige, Allison
CANADIAN FAMILY PHYSICIAN, 2023, 69 (09) : 627 - 627
[16] Naltrexone/Bupropion (Contrave) for Weight Loss
Early, Jessica
Whitten, Jean Suzin
AMERICAN FAMILY PHYSICIAN, 2015, 91 (08) : 554 - +
[17] Bupropion and Naltrexone in Methamphetamine Use Disorder
Trivedi, Madhukar H.
Walker, Robrina
Ling, Walter
dela Cruz, Adriane
Sharma, Gaurav
Carmody, Thomas
Ghitza, Udi E.
Wahle, Aimee
Kim, Mora
Shores-Wilson, Kathy
Sparenborg, Steven
Coffin, Phillip
Schmitz, Joy
Wiest, Katharina
Bart, Gavin
Sonne, Susan C.
Wakhlu, Sidarth
Rush, A. John
Nunes, Edward V.
Shoptaw, Steven
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02): : 140 - 153
[18] Bupropion and naltrexone association on obesity treatment
Ogura, Bianca Ayumi
Mascarenhas, Nayandra Malta
da Silva, Lia Aguiar
Rampazzo, Maria Clara Semprebom
Perek, Ellen Cristina
de Almeida, Georgia Fernandes
Gasques, Luciano Seraphim
RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO, 2024, 18 (117): : 1295 - 1306
[19] Combination therapy with naltrexone and bupropion for obesity
Billes, Sonja K.
Greenway, Frank L.
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1813 - 1826
[20] Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]
Lyu, Young Sang
Ahn, Hongyup
Hong, Sangmo
Park, Cheol-Young
DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 65 - 66

← 1 2 3 4 5 →